GBCS Insider Trading
SELECTIS HEALTH, INC. | Real Estate Investment Trusts
Comprehensive Trading Performance Summary
The investment history of corporate insiders at SELECTIS HEALTH, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Real Estate Investment Trusts sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-15 05:50 | 2025-12-18 | Baller Lance | Director, 10% owner | BUY | $2.20 | 6,192 | $13,622 | 52,808 | +13.3% |
| 2022-10-07 22:11 | 2022-10-06 | Baller Lance | Director, Officer - CEO | BUY | $5.96 | 500 | $2,980 | 161,965 | +0.3% |
| 2021-07-15 19:51 | 2021-07-09 | NEUMAN CLIFFORD L ESQ | Director | BUY | $0.50 | 100,000 | $50,000 | 1,178,637 | +9.3% |
| 2021-07-13 21:35 | 2021-07-09 | Barker Christopher R. | Director, Officer - PRESIDENT AND COO | BUY | $0.50 | 50,000 | $25,000 | 801,341 | +6.7% |
| 2021-07-13 21:36 | 2021-07-09 | Thall Brandon | Officer - CFO | BUY | $0.50 | 20,000 | $10,000 | 20,000 | +100.0% |
| 2017-12-22 00:18 | 2017-12-20 | SINK ANDREW L | Director | BUY | $0.50 | 25,000 | $12,498 | 58,000 | +75.8% |
| 2017-12-21 20:13 | 2017-12-19 | SINK ANDREW L | Director | BUY | $0.44 | 33,000 | $14,401 | 33,000 | +100.0% |
| 2016-01-13 00:48 | 2016-01-08 | BATHGATE STEVEN MARK | Director | BUY | $0.73 | 13,000 | $9,490 | 53,000 | +32.5% |
| 2016-01-08 00:48 | 2016-01-06 | SINK ANDREW L | Director, Officer - COO | BUY | $0.75 | 25,000 | $18,830 | 99,441 | +33.6% |
| 2016-01-08 00:08 | 2016-01-05 | Baller Lance | Director, Officer - Interim CEO and President | BUY | $0.74 | 51,600 | $37,972 | 629,275 | +8.9% |
| 2015-12-24 20:21 | 2015-12-17 | Baller Lance | Director | BUY | $0.65 | 23,340 | $15,171 | 577,675 | +4.2% |
| 2015-09-24 22:58 | 2015-09-03 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.90 | 1,800 | $1,620 | 140,936 | +1.3% |
| 2015-09-18 18:56 | 2015-09-17 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.95 | 2,750 | $2,613 | 143,686 | +2.0% |
| 2015-09-11 23:54 | 2015-09-09 | Baller Lance | Director | BUY | $0.86 | 48,000 | $41,251 | 554,335 | +9.5% |
| 2015-09-04 01:31 | 2015-08-31 | SINK ANDREW L | Director | BUY | $0.90 | 31,179 | $27,924 | 74,441 | +72.1% |
| 2015-09-02 20:55 | 2015-08-31 | SINK ANDREW L | Director | BUY | $0.65 | 31,179 | $20,363 | 74,441 | +72.1% |
| 2015-09-01 00:51 | 2015-08-21 | BROGDON CONNIE B | Other | BUY | $1.02 | 2,800 | $2,856 | 92,000 | +3.1% |
| 2015-09-01 00:53 | 2015-08-21 | Brogdon Christopher F | Director, Officer - President, CEO | BUY | $1.02 | 2,800 | $2,856 | 92,000 | +3.1% |
| 2015-06-04 23:33 | 2015-06-03 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.90 | 3,000 | $2,700 | 38,300 | +8.5% |
| 2015-05-28 22:00 | 2015-05-22 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.95 | 1,300 | $1,235 | 139,136 | +0.9% |
| 2015-05-21 23:15 | 2015-05-18 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.95 | 1,700 | $1,615 | 137,836 | +1.2% |
| 2015-05-14 00:16 | 2015-05-08 | BROGDON CONNIE B | Other | BUY | $0.95 | 1,000 | $950 | 89,200 | +1.1% |
| 2015-05-14 00:14 | 2015-05-08 | Brogdon Christopher F | Director, Officer - President, CEO | BUY | $0.95 | 1,000 | $950 | 89,200 | +1.1% |
| 2015-04-09 22:43 | 2015-04-07 | BROGDON CONNIE B | Other | BUY | $0.92 | 3,000 | $2,745 | 88,200 | +3.5% |
| 2015-04-09 22:41 | 2015-04-07 | Brogdon Christopher F | Director, Officer - President and CEO | BUY | $0.92 | 3,000 | $2,745 | 88,200 | +3.5% |
| 2015-03-26 22:29 | 2015-03-24 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.90 | 10,000 | $9,000 | 136,136 | +7.9% |
| 2015-03-20 22:13 | 2015-03-13 | BROGDON CONNIE B | Other | BUY | $0.91 | 5,000 | $4,550 | 85,200 | +6.2% |
| 2015-03-20 22:05 | 2015-03-13 | Brogdon Christopher F | Director, Officer - CEO, President | BUY | $0.91 | 5,000 | $4,550 | 85,200 | +6.2% |
| 2015-03-16 22:21 | 2015-03-10 | BROGDON CONNIE B | Other | BUY | $0.89 | 2,000 | $1,780 | 80,200 | +2.6% |
| 2015-03-16 22:17 | 2015-03-10 | Brogdon Christopher F | Director, Officer - Pres/CEO/Director | BUY | $0.89 | 2,000 | $1,780 | 80,200 | +2.6% |
| 2015-01-28 00:45 | 2015-01-14 | BROGDON CONNIE B | Officer - spouse of Pres/CEO | BUY | $0.91 | 500 | $455 | 78,200 | +0.6% |
| 2015-01-28 00:41 | 2015-01-14 | Brogdon Christopher F | Director, Officer - Pres/CEO | BUY | $0.91 | 500 | $455 | 78,200 | +0.6% |
| 2015-01-09 21:53 | 2015-01-05 | BROGDON CONNIE B | Other | BUY | $0.95 | 11,100 | $10,534 | 77,700 | +16.7% |
| 2014-12-08 23:18 | 2014-08-14 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.98 | 3,300 | $3,220 | 76,136 | +4.5% |
| 2014-10-23 23:17 | 2014-10-22 | BROGDON CONNIE B | Other | BUY | $0.95 | 23,800 | $22,610 | 43,300 | +122.1% |
| 2014-10-23 23:11 | 2014-10-20 | Brogdon Christopher F | Director, Officer - Pres/CEO | BUY | $0.95 | 23,800 | $22,610 | 43,300 | +122.1% |
| 2014-09-09 23:02 | 2014-09-03 | BROGDON CONNIE B | Other | BUY | $0.98 | 9,500 | $9,295 | 21,500 | +79.2% |
| 2014-09-09 22:52 | 2014-09-03 | Brogdon Christopher F | Director, Officer - President, CEO | BUY | $0.98 | 9,500 | $9,295 | 21,500 | +79.2% |
| 2014-08-21 18:31 | 2014-08-14 | BROGDON CONNIE B | Other | BUY | $0.97 | 9,000 | $8,730 | 12,000 | +300.0% |
| 2014-08-21 18:25 | 2014-08-14 | Brogdon Christopher F | Director, Officer - President, CEO | BUY | $0.97 | 9,000 | $8,730 | 12,000 | +300.0% |
| 2014-08-13 22:06 | 2014-08-07 | Brogdon Christopher F | Director, Officer - President, CEO | BUY | $0.97 | 1,000 | $970 | 3,000 | +50.0% |
| 2014-08-12 22:07 | 2014-08-07 | BROGDON CONNIE B | Other | BUY | $0.97 | 1,000 | $970 | 3,000 | +50.0% |
| 2014-07-25 23:18 | 2014-07-23 | SCARBOROUGH PHILIP S | Officer - CFO | BUY | $0.90 | 7,010 | $6,309 | 72,836 | +10.6% |
| 2014-03-27 20:09 | 2014-03-25 | Brogdon Christopher F | Director, Officer - President / CEO | BUY | $1.13 | 1,900 | $2,155 | 572,268 | +0.3% |
| 2014-02-21 21:14 | 2014-02-20 | SCATES RYAN | Officer - Secretary | BUY | $0.75 | 13,334 | $10,001 | 13,334 | +100.0% |
| 2014-02-21 20:59 | 2014-02-20 | Brogdon Christopher F | Director, Officer - Pres/CEO | BUY | $0.75 | 75,000 | $56,250 | 570,368 | +15.1% |
| 2014-02-21 21:06 | 2014-02-20 | BATHGATE STEVEN MARK | Director | BUY | $0.75 | 25,000 | $18,750 | 25,000 | +100.0% |
| 2014-01-06 21:36 | 2013-12-31 | BATHGATE STEVEN MARK | Director | BUY | $0.75 | 35,000 | $26,250 | 534,113 | +7.0% |
| 2005-04-29 23:29 | 2005-04-28 | NEUMAN CLIFFORD L ESQ | Director, 10% owner | BUY | $0.00 | 0 | $0 | 100,000 | 0.0% |
| 2004-08-31 00:49 | 2004-08-26 | JENNINGS FRANK L | Director, Officer, 10% owner - Principal Exec. Officer & CFO | BUY | $0.20 | 200,000 | $40,000 | 200,000 | +100.0% |
How to Interpret $GBCS Trades
Not every insider transaction in SELECTIS HEALTH, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $GBCS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for GBCS
Insider activity data for SELECTIS HEALTH, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $GBCS, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.